Management of dyspnea in cancer patients

Abstract

Dyspnea (defined as "an uncomfortable sensation of breathing") is one of the most frequent and refractory symptoms of lung cancer patients. Dyspnea decreases the quality of life of both patients and their families. If also affects their treatment process and even prognosis. Therefore it is very important to evaluate and manage dyspnea appropriately. To treat the underlying causes (e.g. drainage of pleural effusion etc.) is the first line. However, the underlying causes are often irreversible and untreatable. It is important to estimate life expectancy by using the Palliative Prognostic Index. It was confirmed that morphine alleviates dyspnea Anxiolytics and corticosteroids also alleviate dyspnea in some cases. Since dyspnea in cancer patients has multidimensional aspects, an interdisciplinary team approach for the symptom management is important. © 2009 The Japan Lung Cancer Society.